![](/img/cover-not-exists.png)
1190 DANOPREVIR PLUS PEG-IFNa-2A/RIBAVIRIN FOR 12 WEEKS RESULTS IN DURABLE VIRAL SUPPRESSION AND LOW RATES OF RESISTANCE THROUGHOUT TREATMENT AND FOLLOW-UP: RESULTS FROM THE ATLAS STUDY
Le Pogam, S., Navarro, M., Thomas, D.N., Klumpp, K., Nájera, I.Volume:
56
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(12)61202-1
Date:
April, 2012
File:
PDF, 79 KB
english, 2012